Philippe Moingeon

Title: Innovations and Contributions of Philippe Moingeon

Introduction

Philippe Moingeon is a notable inventor based in Verrieres le Buisson, France. He has made significant contributions to the field of allergology and immunotherapy, holding a total of 14 patents. His work focuses on reducing the genotoxicity of pollen extracts and improving the efficacy of allergen immunotherapy.

Latest Patents

One of his latest patents is titled "Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids." This invention relates to grass pollen extracts that contain a reduced amount of flavonoid glycosides, which are known to minimize the risks of genotoxicity. The method of preparing these extracts involves ultrafiltration, effectively reducing the presence of harmful flavonoid aglycones. Another significant patent is "IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy." This invention utilizes IL-10 as a biological marker to predict how responsive a house dust mite allergic patient will be to immunotherapy.

Career Highlights

Philippe Moingeon has worked with prominent companies in the field, including Stallergenes and Stallergenes S.A. His career has been marked by a commitment to advancing research in allergy treatment and improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Philippe has collaborated with notable colleagues such as Emmanuel Nony and Thierry Batard. These partnerships have contributed to the development of his groundbreaking inventions and patents.

Conclusion

Philippe Moingeon's work exemplifies the impact of innovation in the field of allergology. His patents and collaborations highlight his dedication to improving health outcomes for allergy sufferers. His contributions continue to influence the landscape of immunotherapy and allergen research.